Pro-Dex, Inc. (PDEX) Stock Analysis & Investment Frameworks
Pro-Dex, Inc. (PDEX) stock analysis on Invetso. Review Pro-Dex, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Pro-Dex, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: US
Pro-Dex, Inc. Key Financial Metrics
- Market Cap: $202.10M
- Revenue: $77.55M
- P/E Ratio: 14.79
- ROE: 26.18%
- ROIC: 15.55%
- Dividend Yield: N/A
About Pro-Dex, Inc.
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.